Phase I study of cisplatin, docetaxel an
Phase I study of cisplatin, docetaxel and irinotecan for advanced non-small cell lung cancer (NSCLC)
β
Kiura, K; Ueoka, H; Eguchi, K; Segawa, Y; Takigawa, N; Kamei, H; Shibayama, T; H
π
Article
π
2000
π
Elsevier Science
π
English
β 105 KB